Product image of Zoledronsyre Sun (Zoledronic Acid Monohydrate) supplied by GNH India

Zoledronsyre Sun

Active Ingredient:
Zoledronic Acid Monohydrate
Origin:
EU

Zoledronsyre Sun (Zoledronic Acid Monohydrate)

Zoledronsyre Sun is a bisphosphonate medication used to prevent bone complications in patients with bone metastases. This intravenous treatment helps reduce bone pain and fracture risk. It is prescribed under medical supervision for osteoporosis and bone disease management. Commonly used in oncology and orthopedic care.

Manufacturer / TM Owner

Sun Pharmaceutical Industries Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zoledronsyre Sun is primarily used to treat bone metastases, a condition where cancer has spread to the bones. It helps reduce bone pain, fractures, and other complications by slowing bone loss. The medication is also prescribed for osteoporosis to strengthen bones and reduce fracture risk. It is administered intravenously under healthcare supervision.

Side Effects

  • This medication works by slowing bone breakdown, which helps maintain bone density and reduce fracture risk. Patients may experience improved mobility and reduced bone pain over time. Some individuals notice a general sense of well-being as bone health stabilizes. Effects vary based on individual health conditions and treatment duration.

Precautions & Warnings

  • Zoledronsyre Sun should only be administered by a healthcare professional in a clinical setting. Patients must stay well-hydrated before and after treatment to reduce kidney strain. Regular monitoring of kidney function and calcium levels is recommended. Inform your doctor of any kidney issues or allergies before starting this medication.

Avoid Interactions

  • This medication may interact with other drugs affecting kidney function, such as diuretics or NSAIDs. Combining it with calcium or vitamin D supplements may require dose adjustments. Alcohol and tobacco use can increase bone loss risks. Always disclose all medications and supplements to your healthcare provider before treatment.

Frequently Asked Questions

Zoledronic acid is used to treat bone metastases and osteoporosis by reducing bone loss and fracture risk.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Consult your doctor before combining it with other drugs, especially those affecting kidney function or bone health.

Common effects may include flu-like symptoms, bone pain, and nausea. Severe reactions require immediate medical attention.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zoledronic Acid Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT